BIOCEPT INC

Services-Medical Laboratories·SAN DIEGO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q2 2023	6/30/23	8/14/23	→
10-Q	Q1 2023	3/31/23	5/10/23	→
10-K	FY 2022	12/31/22	4/17/23	→
10-Q/A	Q3 2022	9/30/22	4/17/23	→
10-Q	Q3 2022	9/30/22	11/21/22	→
10-Q	Q2 2022	6/30/22	11/10/22	→
↓

Earnings Releases (8-K)

25 shown

Filed	Period
8/22/23	Q3 FY2023	→
5/15/23	Q2 FY2023	→
4/17/23	Q1 FY2023	→
1/6/23	Q4 FY2023	→
11/21/22	Q4 FY2022	→
11/14/22	Q4 FY2022	→
↓

News (8-K)

55 shown

Filed	Type	Description
10/20/23	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
10/16/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/21/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
5/16/23	Other	Material Modification to Rights of Security Holders	→
4/17/23	Restatement	Non-Reliance on Previously Issued Financial Statements	→
4/10/23	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
5/25/23	424B4	424B4	→
5/23/23	S-1/A	S-1/A	→
5/19/23	S-1/A	S-1/A	→
5/16/23	S-1/A	S-1/A	→
5/15/23	S-1/A	S-1/A	→
4/20/23	S-1	S-1	→
↓

Filing History(616 filings)

TypeDateAccessionPeriodSize

25-NSE

Nov 20, 2023

0001354457-23-000871

—

3.5 KB

8-K

Oct 20, 2023

0001654954-23-013182FORM 8-K

Oct 16, 2023

146.3 KB

8-K

Oct 16, 2023

0001654954-23-012952FORM 8-K

Oct 13, 2023

141.2 KB

8-K

Aug 22, 2023

0001193125-23-2179978-K

Aug 14, 2023

208.6 KB

10-Q

Aug 14, 2023

0000950170-23-04246810-Q

Jun 30, 2023

8.5 MB

8-K

Jun 21, 2023

0001193125-23-1711488-K

Jun 16, 2023

139.4 KB

Jun 20, 2023

0001209191-23-038625FORM 3 SUBMISSION

Jun 16, 2023

4.0 KB

SC 13G

Jun 2, 2023

0000929638-23-001627

—

79.3 KB

424B4

May 25, 2023

0001193125-23-154367424B4

—

226.6 KB

EFFECT

May 24, 2023

9999999995-23-001517

—

1.6 KB

CORRESP

May 23, 2023

0001193125-23-151173

—

5.8 KB

CORRESP

May 23, 2023

0001193125-23-151169

—

6.1 KB

S-1/A

May 23, 2023

0001193125-23-151164S-1/A

—

537.3 KB

CORRESP

May 19, 2023

0001193125-23-149454

—

5.0 KB

CORRESP

May 19, 2023

0001193125-23-149444

—

5.9 KB

S-1/A

May 19, 2023

0001193125-23-149430S-1/A

—

450.7 KB

CORRESP

May 18, 2023

0001193125-23-148004

—

5.5 KB

CORRESP

May 18, 2023

0001193125-23-148000

—

5.2 KB

CORRESP

May 16, 2023

0001193125-23-146114

—

5.0 KB

CORRESP

May 16, 2023

0001193125-23-146106

—

5.9 KB

S-1/A

May 16, 2023

0001193125-23-146104S-1/A

—

451.1 KB

8-K

May 16, 2023

0001193125-23-1457058-K

May 16, 2023

153.9 KB

S-1/A

May 15, 2023

0001193125-23-144138S-1/A

—

709.2 KB

8-K

May 15, 2023

0001193125-23-1440308-K

May 10, 2023

223.5 KB

10-Q

May 10, 2023

0000950170-23-02065410-Q

Mar 31, 2023

6.8 MB

25 filings shown

Filed	Form	Description
4/21/23	DEFR14A	DEFR14A	→
4/20/23	DEF 14A	DEF 14A	→
4/10/23	PRE 14A	PRE 14A	→
6/27/22	DEFA14A	DEFA14A	→
6/13/22	DEFA14A	DEFA14A	→
5/2/22	DEF 14A	DEF 14A	→
↓

BIOCEPT INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(616 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
6/20/23	3	FORM 3 SUBMISSION	→
6/2/23	SC 13G	SC 13G	→
11/18/22	4	FORM 4 SUBMISSION	→
11/18/22	3	FORM 3 SUBMISSION	→
9/8/22	4	FORM 4 SUBMISSION	→
9/8/22	4	FORM 4 SUBMISSION	→
↓

Filed	Form	Description
11/20/23	25-NSE	25-NSE	→
5/24/23	EFFECT	EFFECT	→
5/8/20	EFFECT	EFFECT	→
12/9/19	EFFECT	EFFECT	→
6/6/19	D	D	→
4/22/19	EFFECT	EFFECT	→
↓